Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Morphic Holding, Inc. (MORF)  
$28.68 0.06 (0.21%) as of 4:30 Mon 5/13


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 49,740,000
Market Cap: 1.43(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $19.95 - $62.11
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 7.4
Insider 3/6 Months : 8
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Morphic is a biopharmaceutical company. Co. is applying its proprietary insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with various approved injectable blockbuster drugs for the treatment of chronic diseases, including autoimmune, cardiovascular and metabolic diseases, fibrosis and cancer. Co. is developing its pipeline, including its main product candidate, MORF-057, an a4ss7-specific integrin inhibitor affecting inflammation, into clinical development for the treatment of inflammatory bowel disease. Co. has also developed selective oral avss6-specific integrin inhibitors including MORF-720 and MORF-627.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 4,776 4,776 1,054,776
Total Buy Value $0 $98,239 $98,239 $47,348,239
Total People Bought 0 2 2 3
Total Buy Transactions 0 2 2 3
Total Shares Sold 0 35,876 89,165 317,833
Total Sell Value $0 $986,256 $4,041,896 $15,087,539
Total People Sold 0 5 5 5
Total Sell Transactions 0 5 14 29
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 366
  Page 5 of 15  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Rogers Bruce Chief Scientific Officer   •       –      –    2021-09-10 4 AS $65.11 $539,078 D/D (8,279) 89,905 -38%     
   Rogers Bruce Chief Scientific Officer   •       –      –    2021-09-10 4 OE $4.32 $35,765 D/D 8,279 98,184     -
   Rogers Bruce Chief Scientific Officer   •       –      –    2021-09-09 4 AS $59.99 $1,829,093 D/D (30,000) 89,905 -33%     
   Rogers Bruce Chief Scientific Officer   •       –      –    2021-09-09 4 OE $4.32 $129,600 D/D 30,000 119,905     -
   Springer Timothy A Director   –       •       •   2021-08-20 4 B $56.01 $659,944 I/I 11,620 912,241 2.25 -17%     
   Springer Timothy A Director   –       •       •   2021-08-19 4 B $54.71 $1,865,010 I/I 33,000 900,621 2.25 -15%     
   Springer Timothy A Director   –       •       •   2021-08-18 4 B $55.42 $1,688,202 I/I 30,307 867,621 2.25 -12%     
   Farrell Robert E Jr SVP Finance and CAO   •       –      –    2021-06-18 4 AS $65.00 $13,000 D/D (200) 17,934 -8%     
   Farrell Robert E Jr SVP Finance and CAO   •       –      –    2021-06-18 4 OE $4.32 $864 D/D 200 18,134     -
   Farrell Robert E Jr SVP Finance and CAO   •       –      –    2021-06-16 4 AS $65.00 $19,501 D/D (300) 17,934 -10%     
   Farrell Robert E Jr SVP Finance and CAO   •       –      –    2021-06-16 4 OE $4.32 $1,296 D/D 300 18,234     -
   Farrell Robert E Jr SVP Finance and CAO   •       –      –    2021-06-14 4 AS $65.00 $229,200 D/D (3,526) 17,934 -12%     
   Farrell Robert E Jr SVP Finance and CAO   •       –      –    2021-06-14 4 OE $4.32 $15,232 D/D 3,526 21,460     -
   Farrell Robert E Jr SVP Finance and CAO   •       –      –    2021-06-10 4 AS $60.08 $961,219 D/D (16,000) 17,934 -11%     
   Farrell Robert E Jr SVP Finance and CAO   •       –      –    2021-06-10 4 OE $4.32 $69,120 D/D 16,000 33,934     -
   Linde Peter Chief Medical Officer   •       –      –    2021-06-01 4 AS $49.72 $299,110 D/D (6,000) 4,600 14%     
   Springer Timothy A Director   –       •       •   2021-05-26 4 B $46.93 $1,174,300 I/I 25,000 837,314 2.25 12%     
   Springer Timothy A Director   –       •       •   2021-05-25 4 B $45.83 $2,981,381 I/I 65,000 812,314 2.25 19%     
   Springer Timothy A Director   –       •       •   2021-05-24 4 B $45.43 $1,860,311 I/I 40,000 747,314 2.25 19%     
   Springer Timothy A Director   –       •       •   2021-05-21 4 B $45.50 $10,569,423 I/I 232,295 707,314 2.25 24%     
   Nashat Amir Director   –       •      –    2021-05-21 4 S $45.50 $10,569,423 I/I (232,295) 136,691 -24%     
   Stampacchia Otello Director   –       •      –    2021-04-30 4 AS $54.26 $523,075 D/D (9,487) 2,068,913 9%     
   Stampacchia Otello Director   –       •      –    2021-04-29 4 AS $53.37 $414,587 D/D (7,671) 2,078,400 11%     
   Stampacchia Otello Director   –       •      –    2021-04-28 4 AS $55.36 $187,536 D/D (3,366) 2,086,071 15%     
   Stampacchia Otello Director   –       •      –    2021-04-27 4 AS $54.60 $405,718 D/D (7,338) 2,089,437 13%     
  366 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 5 of 15
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us